(Q37735169)

22 August 2017

1 reference

title

Investigational melatonin receptor agonists (English)

1 reference

22 August 2017

0 references

1

Rüdiger Hardeland

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 June 2010

1 reference

Expert Opinion on Investigational Drugs

22 August 2017

published in

1 reference

22 August 2017

volume

19

1 reference

22 August 2017

issue

6

1 reference

22 August 2017

page(s)

747-764

1 reference

Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Melatonin, hormone of darkness and more: occurrence, control mechanisms, actions and bioactive metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Melatonin: signaling mechanisms of a pleiotropic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Melatonin as a chronobiotic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Human circadian rhythms: physiological and therapeutic relevance of light and melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Clinical update: melatonin and sleep disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Physiological and metabolic functions of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Melatonin as antioxidant, geroprotector and anticarcinogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Melatonin and ischemia-reperfusion injury of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Drug Insight: the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Melatonin and melatonergic drugs on sleep: possible mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

The basic physiology and pathophysiology of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Ramelteon: a novel treatment for the treatment of insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Melatonin shifts human circadian rhythms according to a phase-response curve

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Melatonin: Nature's most versatile biological signal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Targeted disruption of the mouse Mel(1b) melatonin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Functional MT1 and MT2 melatonin receptors in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Mice, melatonin and the circadian system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Mammalian melatonin receptors: molecular biology and signal transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Hypothalamic regulation of sleep and circadian rhythms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Neurobiology of the sleep-wake cycle: sleep architecture, circadian regulation, and regulatory feedback

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

The role of the thalamus in sleep, pineal melatonin production, and circadian rhythm sleep disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Sleep spindles: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Role of melatonin in the regulation of human circadian rhythms and sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Late evening brain activation patterns and their relation to the internal biological time, melatonin, and homeostatic sleep debt

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Pathophysiology of depression: role of sleep and the melatonergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Melatonin effect on seizures in children with severe neurologic deficit disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

The role of ML-23 and other melatonin analogues in the treatment and management of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

A single blind, placebo controlled, across groups dose escalation study of the safety, tolerability, pharmacokinetics and pharmacodynamics of the melatonin analog beta-methyl-6-chloromelatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Antagonism of serotonergic 5-HT2A/2C receptors: mutual improvement of sleep, cognition and mood?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Melatonin receptor agonists: SAR and applications to the treatment of sleep-wake disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Preclinical pharmacokinetics and metabolism of BMS-214778, a novel melatonin receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

NEU-P11, a novel melatonin agonist, inhibits weight gain and improves insulin sensitivity in high-fat/high-sucrose-fed rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Melatonin in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Circadian genes, rhythms and the biology of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Melatonin and human chronobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacological considerations, and new therapeutic vistas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Preoperative anxiolytic effect of melatonin and clonidine on postoperative pain and morphine consumption in patients undergoing abdominal hysterectomy: a double-blind, randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Melatonin provides anxiolysis, enhances analgesia, decreases intraocular pressure, and promotes better operating conditions during cataract surgery under topical anesthesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

The role of melatonin in the immuno-neuro-psychology of mental disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Melatonin does not reduce anxiety more than placebo in the elderly undergoing surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Agomelatine(S 20098) antagonizes the penile erections induced by the stimulation of 5-HT2C receptors in Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Novel non-indolic melatonin receptor agonists differentially entrain endogenous melatonin rhythm and increase its amplitude

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Pharmacological characterization of human recombinant melatonin mt(1) and MT(2) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Mechanisms of melatonin-induced vasoconstriction in the rat tail artery: a paradigm of weak vasoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Chronobiotic effects of the melatonin agonist LY 156735 following a simulated 9h time shift: results of a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Let there be sleep--on time

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Circadian rhythm abnormalities of melatonin in Smith-Magenis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Inverted rhythm of melatonin secretion in Smith-Magenis syndrome: from symptoms to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Circadian rhythm disorder in a rare disease: Smith-Magenis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Smith-Magenis syndrome: a case report of improved sleep after treatment with beta1-adrenergic antagonists and melatonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

Parkinson's disease as a neuroendocrine disorder of circadian function: dopamine-melatonin imbalance and the visual system in the genesis and progression of the degenerative process

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

The Efficacy and Safety of the Melatonin Agonist beta-Methyl-6-Chloromelatonin in Primary Insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.482926

10.1517/13543784.2010.482926

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference